J9258 — Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg
J9258 is a HCPCS Level II code for injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on September 30, 2024 and is not valid on new claims.
This code has been terminated
CMS terminated J9258 on September 30, 2024. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J9258
- Long descriptor
- Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg
- Short descriptor
- Paclitaxel (teva)
- Added
- January 1, 2024
- Terminated
- September 30, 2024
- BETOS
- O1D
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J9258
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J9258 is not quite right, the correct code is very often within a few positions of it.
- J9245Injection, melphalan hydrochloride, not otherwise specified, 50 mg
- J9246Injection, melphalan (evomela), 1 mg
- J9247Injection, melphalan flufenamide, 1mgterminated
- J9248Injection, melphalan (hepzato), 1 mg
- J9249Injection, melphalan (apotex), 1 mg
- J9250Methotrexate sodium, 5 mgterminated
- J9255Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg
- J9256Injection, nipocalimab-aahu, 3 mg
- J9259Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mgterminated
- J9260Injection, methotrexate sodium, 50 mg
- J9261Injection, nelarabine, 50 mg
- J9262Injection, omacetaxine mepesuccinate, 0.01 mg
- J9263Injection, oxaliplatin, 0.5 mg
- J9264Injection, paclitaxel protein-bound particles, 1 mg
- J9265Injection, paclitaxel, 30 mgterminated
- J9266Injection, pegaspargase, per single dose vial
Questions about J9258
What is HCPCS code J9258?
J9258 is a HCPCS Level II code for injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J9258?
The CMS HCPCS file marks J9258 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J9258 still valid?
No. J9258 was terminated on September 30, 2024 and should not be used on new claims.